DIGITALEUROPE is proud to introduce Turbine, nominated by IVSZ, among the selected SMEs to participate in the Future Unicorn Award. This Hungarian eHealth company is innovating and enhancing the discovery processes of cancer drugs with their Simulated Cell.
Designing life-saving therapies today requires a vast investment of money, brainpower, and time. Still, failure is the result 99 times out of 100. The reason for this is simple – mankind doesn’t understand how human biology works. Turbine was founded on the premise that a predictive, computational model of biology would revolutionize drug discovery much like computer-aided design revolutionized engineering.
Turbine’s growing team of AI experts, biologists and data scientists have spent the past decade building this model. Now, researchers can design and refine therapies before running years of costly biological experiments. Through millions of simulated experiments, Turbine finds the shortest, safest route to new patient therapies, enabling researchers to focus their resources on fighting disease in the most effective way possible.
The Pan-European Future Unicorn Award aims to highlight innovative SMEs that have the potential to become Europe’s next unicorns. The award is compiled by asking all the national trade associations affiliated with DIGITALEUROPE to nominate a single SME from their country. This results in a truly pan-European selection of incredible digital companies from all sectors.
The award will be delivered at our flagship event, Masters of Digital, in Brussels on 21 February.
For more information about the award please contact Yann Finger.